207 related articles for article (PubMed ID: 27655164)
1. [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].
Fischer N; Rostaher A; Favrot C
Schweiz Arch Tierheilkd; 2016 Sep; 158(9):646-652. PubMed ID: 27655164
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis.
Timm K; Mueller RS; Nett-Mettler CS
Vet Dermatol; 2018 Apr; 29(2):123-e49. PubMed ID: 29327474
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
Fischer NM; Rostaher A; Favrot C
Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of short-term combination of intralymphatic allergen immunotherapy and lokivetmab treatment in canine atopic dermatitis: A double-blinded, controlled, randomised study.
van Amersfort K; Vernooij JCM; van der Lee A
Vet Dermatol; 2023 Oct; 34(5):373-384. PubMed ID: 37186491
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis.
Hobi S; Mueller RS
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(3):167-73. PubMed ID: 24920143
[TBL] [Abstract][Full Text] [Related]
6. The future of immunotherapy for canine atopic dermatitis: a review.
DeBoer DJ
Vet Dermatol; 2017 Feb; 28(1):25-e6. PubMed ID: 28133873
[TBL] [Abstract][Full Text] [Related]
7. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
Mueller RS; Veir J; Fieseler KV; Dow SW
Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
[TBL] [Abstract][Full Text] [Related]
8. Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.
Fujimura M; Ishimaru H
Pol J Vet Sci; 2016; 19(1):3-6. PubMed ID: 27096781
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis.
Plant JD; Neradilek MB
BMC Vet Res; 2017 Jan; 13(1):4. PubMed ID: 28056956
[TBL] [Abstract][Full Text] [Related]
10. A randomised, double-blinded comparison between subcutaneous rush and intralympathic allergen immunotherapy induction in atopic dogs.
Mueller RS; Zablotski Y; Baumann K; Boehm T; Kasper B; Klinger C; Monke M; Udraite-Vovk L; Weitzer T; Gedon NKY
Vet Dermatol; 2023 Apr; 34(2):91-98. PubMed ID: 36424528
[TBL] [Abstract][Full Text] [Related]
11. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis.
Hylander T; Latif L; Petersson-Westin U; Cardell LO
J Allergy Clin Immunol; 2013 Feb; 131(2):412-20. PubMed ID: 23374268
[TBL] [Abstract][Full Text] [Related]
12. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy.
Griffin CE; Hillier A
Vet Immunol Immunopathol; 2001 Sep; 81(3-4):363-83. PubMed ID: 11553398
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
Mueller RS; Bettenay SV
Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study.
Colombo S; Hill PB; Shaw DJ; Thoday KL
Vet Dermatol; 2005 Jun; 16(3):162-70. PubMed ID: 15960629
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis.
Kawano K; Mizuno T
Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 10 and transforming growth factor-beta 1 plasma levels in atopic dogs before and during immunotherapy.
Martini F; Rostaher A; Favrot C; Fischer N
Vet Rec; 2022 Jun; 190(12):e1270. PubMed ID: 34939678
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of subcutaneous allergen immunotherapy in atopic dogs: A retrospective study of 664 cases.
Fennis EEM; van Damme CMM; Schlotter YM; Sinke JD; Leistra MHG; Bartels RT; Broere F
Vet Dermatol; 2022 Aug; 33(4):321-e75. PubMed ID: 35635279
[TBL] [Abstract][Full Text] [Related]
18. Intralymphatic immunotherapy.
Senti G; Johansen P; Kündig TM
Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):537-43. PubMed ID: 19680119
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
Marsella R
Vet Dermatol; 2010 Dec; 21(6):566-71. PubMed ID: 20492623
[TBL] [Abstract][Full Text] [Related]
20. Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats.
Trimmer AM; Griffin CE; Boord MJ; Rosenkrantz WS
Vet Dermatol; 2005 Oct; 16(5):324-9. PubMed ID: 16238812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
